Hims & Hers Health Registered (A) WKN: A2QMYY ISIN: US4330001060 Forum: Aktien Thema: Hauptdiskussion

Today we announce a strategic investment in $GRAL — the most advanced Multi-Cancer Early Detection (MCED) test on the market. When I was 12, my father was diagnosed with stage 4 colon cancer. He was 38 at the time, about the same age as I am today. Since hearing about early detection cancer tests nearly 5 years ago, I’ve been obsessed with finding ways to get more people I love access. I started with my family a few years back, and most recently my friends. With today’s announcement, I’m now focused on all of you. The ability to detect cancer in its early stages was a dream when I was a kid. It was what I wanted more than anything after my dad was diagnosed. What $GRAL can do today is nothing short of magic. It is flipping cancer diagnosis on its head. Imagine the ability to catch it early. No more surprises, no more “if onlys.” Just a simple, annual blood test that’s as easy as going to the dentist. For many, it could be life-changing, helping you or a family member find out early, when something can hopefully be done. Today’s strategic investment is the first of many like it, in our pursuit to curate the absolute best in advanced healthcare. This deal, though, is special to me, and I couldn’t be more excited to one day bring it to you and the people you love.

Ne glaube die dienen auch immer als Vorgriffsrecht (werden meistens vertraglich für die Beteiligung eingeräumt)

Ist das gesichert, dass die die Diagnostik nutzen können? Ich verstehe solche Beteiligungen (vllt fälschlicherweise) eigentlich immer eher an einem Investment wie wir es an der börse tun.